Inflammation-induced fetal growth restriction in rats is associated with increased placental HIF-1α accumulation

PLoS ONE

Volumn 12, Issue 4, 2017, Pages

  Robb, Kevin P ^a   Cotechini, Tiziana ^a   Allaire, Camille ^a   Sperou, Arissa ^a   Graham, Charles H ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COLONY STIMULATING FACTOR 1; CYTOKINE; GLYCERYL TRINITRATE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 5; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; PIMONIDAZOLE; PLACENTA PROTEIN; SODIUM CHLORIDE; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR; VASCULOTROPIN; FLT1 PROTEIN, RAT; HIF1A PROTEIN, RAT; VASCULOTROPIN RECEPTOR 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; FETUS; GESTATION PERIOD; IMMUNOLOCALIZATION; INFLAMMATION; INTRAUTERINE GROWTH RETARDATION; MATERNAL PLASMA; NONHUMAN; PROTEIN EXPRESSION; RAT; TISSUE SECTION; ANIMAL; CHEMICALLY INDUCED; DISEASE MODEL; DRUG EFFECTS; FETAL GROWTH RETARDATION; GENE EXPRESSION REGULATION; GENETICS; GESTATIONAL AGE; HUMAN; HYPOXIA; IMMUNOLOGY; PATHOLOGY; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; SIGNAL TRANSDUCTION; TRANSDERMAL PATCH; WISTAR RAT;

ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; FETAL GROWTH RETARDATION; GENE EXPRESSION REGULATION; GESTATIONAL AGE; HUMANS; HYPOXIA; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INFLAMMATION; INTERLEUKIN-10; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; NITROGLYCERIN; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION; TRANSDERMAL PATCH; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 85018503969     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0175805     Document Type: Article

References (55)

1. Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science (New York, NY). 2005; 308(5728):1592-4.
2. Rajakumar A, Brandon HM, Daftary A, Ness R, Conrad KP. Evidence for the functional activity of hypoxia-inducible transcription factors overexpressed in preeclamptic placentae. Placenta. 2004; 25 (10):763-9. https://doi.org/10.1016/j.placenta.2004.02.011 PMID: 15451190
3. Caniggia I, Winter JL. Adriana and Luisa Castellucci Award lecture 2001. Hypoxia inducible factor-1: oxygen regulation of trophoblast differentiation in normal and pre-eclamptic pregnancies-a review. Placenta. 2002; 23 Suppl A:S47-57.
4. Rodesch F, Simon P, Donner C, Jauniaux E. Oxygen measurements in endometrial and trophoblastic tissues during early pregnancy. Obstetrics and gynecology. 1992; 80(2):283-5. PMID: 1635745
5. Ness RB, Sibai BM. Shared and disparate components of the pathophysiologies of fetal growth restriction and preeclampsia. American journal of obstetrics and gynecology. 2006; 195(1):40-9. https://doi. org/10.1016/j.ajog.2005.07.049 PMID: 16813742
6. Bartha JL, Romero-Carmona R, Comino-Delgado R. Inflammatory cytokines in intrauterine growth retardation. Acta obstetricia et gynecologica Scandinavica. 2003; 82(12):1099-102. PMID: 14616253
7. Lin D, Smith MA, Elter J, Champagne C, Downey CL, Beck J, et al. Porphyromonas gingivalis infection in pregnant mice is associated with placental dissemination, an increase in the placental Th1/Th2 cytokine ratio, and fetal growth restriction. Infection and immunity. 2003; 71(9):5163-8. https://doi.org/10. 1128/IAI.71.9.5163-5168.2003 PMID: 12933860
8. Borzychowski AM, Sargent IL, Redman CW. Inflammation and pre-eclampsia. Seminars in fetal & neonatal medicine. 2006; 11(5):309-16.
9. Redman CW, Sacks GP, Sargent IL. Preeclampsia: an excessive maternal inflammatory response to pregnancy. American journal of obstetrics and gynecology. 1999; 180(2 Pt 1):499-506. PMID: 9988826
10. Szarka A, Rigo J Jr, Lazar L, Beko G, Molvarec A. Circulating cytokines, chemokines and adhesion molecules in normal pregnancy and preeclampsia determined by multiplex suspension array. BMC immunology. 2010; 11:59. https://doi.org/10.1186/1471-2172-11-59 PMID: 21126355
11. Conrad KP, Miles TM, Benyo DF. Circulating levels of immunoreactive cytokines in women with preeclampsia. American journal of reproductive immunology (New York, NY: 1989). 1998; 40(2):102-11.
12. Kwak-Kim J, Park JC, Ahn HK, Kim JW, Gilman-Sachs A. Immunological modes of pregnancy loss. American journal of reproductive immunology (New York, NY: 1989). 2010; 63(6):611-23.
13. Mallmann P, Mallmann R, Krebs D. Determination of tumor necrosis factor alpha (TNF alpha) and interleukin 2 (IL 2) in women with idiopathic recurrent miscarriage. Archives of gynecology and obstetrics. 1991; 249(2):73-8. PMID: 1953054
14. Vassiliadis S, Ranella A, Papadimitriou L, Makrygiannakis A, Athanassakis I. Serum levels of pro- and anti-inflammatory cytokines in non-pregnant women, during pregnancy, labour and abortion. Mediators of inflammation. 1998; 7(2):69-72. https://doi.org/10.1080/09629359891199 PMID: 9836491
15. Renaud SJ, Cotechini T, Quirt JS, Macdonald-Goodfellow SK, Othman M, Graham CH. Spontaneous pregnancy loss mediated by abnormal maternal inflammation in rats is linked to deficient uteroplacental perfusion. Journal of immunology (Baltimore, Md: 1950). 2011; 186(3):1799-808.
16. Cotechini T, Komisarenko M, Sperou A, Macdonald-Goodfellow S, Adams MA, Graham CH. Inflammation in rat pregnancy inhibits spiral artery remodeling leading to fetal growth restriction and features of preeclampsia. J Exp Med. 2014; 211(1):165-79. https://doi.org/10.1084/jem.20130295 PMID: 24395887
17. Cotechini T, Hopman WJ, Graham CH. Inflammation-induced fetal growth restriction in rats is associated with altered placental morphometrics. Placenta. 2014; 35(8):575-81. https://doi.org/10.1016/j. placenta.2014.05.002 PMID: 24927914
18. Bonello S, Zahringer C, BelAiba RS, Djordjevic T, Hess J, Michiels C, et al. Reactive oxygen species activate the HIF-1alpha promoter via a functional NFkappaB site. Arteriosclerosis, thrombosis, and vascular biology. 2007; 27(4):755-61. https://doi.org/10.1161/01.ATV.0000258979.92828.bc PMID: 17272744
19. Jung Y, Isaacs JS, Lee S, Trepel J, Liu ZG, Neckers L. Hypoxia-inducible factor induction by tumour necrosis factor in normoxic cells requires receptor-interacting protein-dependent nuclear factor kappa B activation. The Biochemical journal. 2003; 370(Pt 3):1011-7. https://doi.org/10.1042/BJ20021279 PMID: 12479793
20. Tal R. The role of hypoxia and hypoxia-inducible factor-1alpha in preeclampsia pathogenesis. Biology of reproduction. 2012; 87(6):134. https://doi.org/10.1095/biolreprod.112.102723 PMID: 23034156
21. Damodaram M, Story L, Kulinskaya E, Rutherford M, Kumar S. Early adverse perinatal complications in preterm growth-restricted fetuses. The Australian & New Zealand journal of obstetrics & gynaecology. 2011; 51(3):204-9.
22. Peleg D, Kennedy CM, Hunter SK. Intrauterine growth restriction: identification and management. American family physician. 1998; 58(2):453-60, 66-7. PMID: 9713399
23. Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. The Journal of clinical investigation. 2003; 111(5):649-58. https://doi.org/10.1172/JCI17189 PMID: 12618519
24. Barsoum IB, Renaud SJ, Graham CH. Glyceryl trinitrate inhibits hypoxia-induced release of soluble fms-like tyrosine kinase-1 and endoglin from placental tissues. The American journal of pathology. 2011; 178(6):2888-96. https://doi.org/10.1016/j.ajpath.2011.02.013 PMID: 21641407
25. Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, et al. Circulating angiogenic factors and the risk of preeclampsia. The New England journal of medicine. 2004; 350(7):672-83. https://doi.org/ 10.1056/NEJMoa031884 PMID: 14764923
26. Venkatesha S, Toporsian M, Lam C, Hanai J, Mammoto T, Kim YM, et al. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nature medicine. 2006; 12(6):642-9. https://doi.org/10.1038/ nm1429 PMID: 16751767
27. Andraweera PH, Dekker GA, Roberts CT. The vascular endothelial growth factor family in adverse pregnancy outcomes. Human reproduction update. 2012; 18(4):436-57. https://doi.org/10.1093/ humupd/dms011 PMID: 22495259
28. Cotechini T, Othman M, Graham CH. Nitroglycerin prevents coagulopathies and foetal death associated with abnormal maternal inflammation in rats. Thrombosis and haemostasis. 2012; 107(5):864-74. https://doi.org/10.1160/TH11-10-0730 PMID: 22274747
29. Varia MA, Calkins-Adams DP, Rinker LH, Kennedy AS, Novotny DB, Fowler WC Jr, et al. Pimonidazole: a novel hypoxia marker for complementary study of tumor hypoxia and cell proliferation in cervical carcinoma. Gynecologic oncology. 1998; 71(2):270-7. https://doi.org/10.1006/gyno.1998.5163 PMID: 9826471
30. Kanasaki K, Palmsten K, Sugimoto H, Ahmad S, Hamano Y, Xie L, et al. Deficiency in catechol-Omethyltransferase and 2-methoxyoestradiol is associated with pre-eclampsia. Nature. 2008; 453 (7198):1117-21. https://doi.org/10.1038/nature06951 PMID: 18469803
31. Kulandavelu S, Whiteley KJ, Qu D, Mu J, Bainbridge SA, Adamson SL. Endothelial nitric oxide synthase deficiency reduces uterine blood flow, spiral artery elongation, and placental oxygenation in pregnant mice. Hypertension. 2012; 60(1):231-8. https://doi.org/10.1161/HYPERTENSIONAHA.111.187559 PMID: 22615111
32. Moffett A, Loke YW. The immunological paradox of pregnancy: a reappraisal. Placenta. 2004; 25(1):1-8. https://doi.org/10.1016/S0143-4004(03)00167-X PMID: 15013633
33. Challis JR, Lockwood CJ, Myatt L, Norman JE, Strauss JF 3rd, Petraglia F. Inflammation and pregnancy. Reproductive sciences (Thousand Oaks, Calif). 2009; 16(2):206-15.
34. Cotechini T, Graham CH. Aberrant maternal inflammation as a cause of pregnancy complications: A potential therapeutic target? Placenta. 2015.
35. Elfayomy AK, Habib FA, Almasry SM, Safwat MD, Eldomiaty MA. Serum levels of adrenomedullin and inflammatory cytokines in women with term idiopathic intrauterine growth restriction. Journal of obstetrics and gynaecology: the journal of the Institute of Obstetrics and Gynaecology. 2013; 33(2):135-9.
36. Mullins E, Prior T, Roberts I, Kumar S. Changes in the maternal cytokine profile in pregnancies complicated by fetal growth restriction. American journal of reproductive immunology (New York, NY: 1989). 2012; 68(1):1-7.
37. Lausten-Thomsen U, Olsen M, Greisen G, Schmiegelow K. Inflammatory markers in umbilical cord blood from small-for-gestational-age newborns. Fetal and pediatric pathology. 2014; 33(2):114-8. https://doi.org/10.3109/15513815.2013.879239 PMID: 24476425
38. Mullins E, Prior T, Roberts I, Kumar S. Changes in the fetal and neonatal cytokine profile in pregnancies complicated by fetal growth restriction. American journal of reproductive immunology (New York, NY: 1989). 2013; 69(5):441-8.
39. Borzychowski AM, Sargent IL, Redman CWG. Inflammation and pre-eclampsia. Seminars in Fetal and Neonatal Medicine. 2006; 11(5):309-16. https://doi.org/10.1016/j.siny.2006.04.001 PMID: 16828580
40. Redman CW, Sargent IL. Immunology of pre-eclampsia. American journal of reproductive immunology (New York, NY: 1989). 2010; 63(6):534-43.
41. Huang SJ, Zenclussen AC, Chen CP, Basar M, Yang H, Arcuri F, et al. The implication of aberrant GM- CSF expression in decidual cells in the pathogenesis of preeclampsia. Am J Pathol. 2010; 177 (5):2472-82. https://doi.org/10.2353/ajpath.2010.091247 PMID: 20829438
42. Hayashi M, Zhu K, Sagesaka T, Fukasawa I, Inaba N. Elevation of amniotic fluid macrophage colonystimulating factor in normotensive pregnancies that delivered small-for-gestational-age infants. American journal of reproductive immunology (New York, NY: 1989). 2007; 57(6):488-94.
43. Jiang BH, Semenza GL, Bauer C, Marti HH. Hypoxia-inducible factor 1 levels vary exponentially over a physiologically relevant range of O2 tension. The American journal of physiology. 1996; 271(4 Pt 1): C1172-80. PMID: 8897823
44. Movafagh S, Crook S, Vo K. Regulation of hypoxia-inducible factor-1a by reactive oxygen species: new developments in an old debate. Journal of cellular biochemistry. 2015; 116(5):696-703. https://doi.org/ 10.1002/jcb.25074 PMID: 25546605
45. Bae YS, Oh H, Rhee SG, Yoo YD. Regulation of reactive oxygen species generation in cell signaling. Molecules and cells. 2011; 32(6):491-509. https://doi.org/10.1007/s10059-011-0276-3 PMID: 22207195
46. Rajakumar A, Doty K, Daftary A, Harger G, Conrad KP. Impaired oxygen-dependent reduction of HIF-1alpha and -2alpha proteins in pre-eclamptic placentae. Placenta. 2003; 24(2-3):199-208. PMID: 12566247
47. Rajakumar A, Michael HM, Daftary A, Jeyabalan A, Gilmour C, Conrad KP. Proteasomal Activity in Placentas from Women with Preeclampsia and Intrauterine Growth Restriction: Implications for Expression of HIF-α Proteins. Placenta. 2008; 29(3):290-9. https://doi.org/10.1016/j.placenta.2007.11.015 PMID: 18222538
48. Neerhof MG, Synowiec S, Khan S, Thaete LG. Pathophysiology of chronic nitric oxide synthase inhibition-induced fetal growth restriction in the rat. Hypertension in pregnancy. 2011; 30(1):28-36. https:// doi.org/10.3109/10641950903322915 PMID: 21265058
49. Helmbrecht GD, Farhat MY, Lochbaum L, Brown HE, Yadgarova KT, Eglinton GS, et al. L-arginine reverses the adverse pregnancy changes induced by nitric oxide synthase inhibition in the rat. American journal of obstetrics and gynecology. 1996; 175(4 Pt 1):800-5. PMID: 8885725
50. Diket AL, Pierce MR, Munshi UK, Voelker CA, Eloby-Childress S, Greenberg SS, et al. Nitric oxide inhibition causes intrauterine growth retardation and hind-limb disruptions in rats. American journal of obstetrics and gynecology. 1994; 171(5):1243-50. PMID: 7977528
51. Kulandavelu S, Whiteley KJ, Bainbridge SA, Qu D, Adamson SL. Endothelial NO synthase augments fetoplacental blood flow, placental vascularization, and fetal growth in mice. Hypertension. 2013; 61 (1):259-66. https://doi.org/10.1161/HYPERTENSIONAHA.112.201996 PMID: 23150513
52. Rennie MY, Rahman A, Whiteley KJ, Sled JG, Adamson SL. Site-specific increases in utero- and fetoplacental arterial vascular resistance in eNOS-deficient mice due to impaired arterial enlargement. Biology of reproduction. 2015; 92(2):48. https://doi.org/10.1095/biolreprod.114.123968 PMID: 25519187
53. Burton GJ, Woods AW, Jauniaux E, Kingdom JC. Rheological and physiological consequences of conversion of the maternal spiral arteries for uteroplacental blood flow during human pregnancy. Placenta. 2009; 30(6):473-82. https://doi.org/10.1016/j.placenta.2009.02.009 PMID: 19375795
54. Tal R, Shaish A, Barshack I, Polak-Charcon S, Afek A, Volkov A, et al. Effects of Hypoxia-Inducible Factor-1α Overexpression in Pregnant Mice: Possible Implications for Preeclampsia and Intrauterine Growth Restriction. The American Journal of Pathology. 2010; 177(6):2950-62. https://doi.org/10. 2353/ajpath.2010.090800 PMID: 20952590
55. Nevo O, Soleymanlou N, Wu Y, Xu J, Kingdom J, Many A, et al. Increased expression of sFlt-1 in in vivo and in vitro models of human placental hypoxia is mediated by HIF-1. American journal of physiology Regulatory, integrative and comparative physiology. 2006; 291(4):R1085-93. https://doi.org/10.1152/ ajpregu.00794.2005 PMID: 16627691